Tricuspid Valve Interventions: Heart Team Discussion, When, Who and What?

Dec 30, 2017 by in CARDIOLOGY Comments Off on Tricuspid Valve Interventions: Heart Team Discussion, When, Who and What?

Primary (leaflet abnormality): 25% Congenital Ebstein’s anomaly   Tricuspid valve tethering associated with perimembranous VSD and VSA   Other (giant right atrium)  Acquired disease Carcinoid   Degenerative (myxomatous)   Endocarditis   Endomyocardial fibrosis   Iatrogenic (pacing…

read more

Transcatheter Interventions for Tricuspid Regurgitation: Rationale, Overview of Current Technologies, and Future Perspectives

Dec 30, 2017 by in CARDIOLOGY Comments Off on Transcatheter Interventions for Tricuspid Regurgitation: Rationale, Overview of Current Technologies, and Future Perspectives

• Flexibility of the TA and the surrounding myocardium (calcification is rare) counteracts fixation and long-term stability of transcatheter tricuspid valve replacement devices and increases the risk of dehiscence of annuloplasty…

read more

Catheter-Based Therapy for Tricuspid Valve Disease: Practical Considerations for Interventionalists

Dec 30, 2017 by in CARDIOLOGY Comments Off on Catheter-Based Therapy for Tricuspid Valve Disease: Practical Considerations for Interventionalists

Large tricuspid annulus dimensions with a non-planar and elliptical shape Absence of calcifications RV morphology (trabeculae, muscle bands, thin apical wall) Proximity/contiguity of other structures (coronary sinus, atrioventricular node and…

read more
Get Clinical Tree app for offline access